vs
莫德纳（MRNA）与RUSH ENTERPRISES INC \TX\（RUSHA）财务数据对比。点击上方公司名可切换其他公司
RUSH ENTERPRISES INC \TX\的季度营收约是莫德纳的1.7倍（$1.7B vs $1.0B），RUSH ENTERPRISES INC \TX\净利率更高（3.7% vs -19.7%，领先23.3%），RUSH ENTERPRISES INC \TX\同比增速更快（-9.0% vs -45.4%），RUSH ENTERPRISES INC \TX\自由现金流更多（$411.6M vs $-880.0M），过去两年RUSH ENTERPRISES INC \TX\的营收复合增速更高（-6.8% vs -45.0%）
莫德纳是一家总部位于美国马萨诸塞州剑桥市的生物制药企业，深耕RNA治疗领域，核心业务聚焦mRNA疫苗研发。其疫苗通过信使RNA（mRNA）分子拷贝传递蛋白合成指令以触发人体免疫反应，公司名称由“修饰”“RNA”与“现代”三个词组合而来。
Rush Enterprises是总部位于美国得克萨斯州新布朗费尔斯的商用车经销商，核心业务是通过旗下Rush Truck Centers销售全新及二手卡车。2019年该公司在全美20个州运营超200家卡车中心，在加拿大设有14个网点，2020年入选财富500强榜单。
MRNA vs RUSHA — 直观对比
营收规模更大
RUSHA
是对方的1.7倍
$1.0B
营收增速更快
RUSHA
高出36.4%
-45.4%
净利率更高
RUSHA
高出23.3%
-19.7%
自由现金流更多
RUSHA
多$1.3B
$-880.0M
两年增速更快
RUSHA
近两年复合增速
-45.0%
损益表 — Q3 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.7B |
| 净利润 | $-200.0M | $61.7M |
| 毛利率 | 79.6% | 20.4% |
| 营业利润率 | -25.6% | 4.9% |
| 净利率 | -19.7% | 3.7% |
| 营收同比 | -45.4% | -9.0% |
| 净利润同比 | -1638.5% | 1.8% |
| 每股收益（稀释后） | $-0.51 | $0.77 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MRNARUSHA
| Q1 26 | — | $1.7B | ||
| Q4 25 | — | $1.7B | ||
| Q3 25 | $1.0B | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | $966.0M | $1.9B | ||
| Q3 24 | $1.9B | $1.8B | ||
| Q2 24 | — | $1.9B |
净利润MRNARUSHA
| Q1 26 | — | $61.7M | ||
| Q4 25 | — | $64.3M | ||
| Q3 25 | $-200.0M | $66.7M | ||
| Q2 25 | — | $72.4M | ||
| Q1 25 | — | $60.3M | ||
| Q4 24 | $-1.1B | $74.8M | ||
| Q3 24 | $13.0M | $79.1M | ||
| Q2 24 | — | $78.7M |
毛利率MRNARUSHA
| Q1 26 | — | 20.4% | ||
| Q4 25 | — | 20.8% | ||
| Q3 25 | 79.6% | 21.0% | ||
| Q2 25 | — | 20.7% | ||
| Q1 25 | — | 20.3% | ||
| Q4 24 | 23.5% | 19.3% | ||
| Q3 24 | 72.4% | 21.0% | ||
| Q2 24 | — | 20.2% |
营业利润率MRNARUSHA
| Q1 26 | — | 4.9% | ||
| Q4 25 | — | 5.5% | ||
| Q3 25 | -25.6% | 5.6% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 5.2% | ||
| Q4 24 | -129.0% | 5.8% | ||
| Q3 24 | -3.8% | 6.7% | ||
| Q2 24 | — | 6.4% |
净利率MRNARUSHA
| Q1 26 | — | 3.7% | ||
| Q4 25 | — | 3.8% | ||
| Q3 25 | -19.7% | 3.7% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 3.4% | ||
| Q4 24 | -115.9% | 3.9% | ||
| Q3 24 | 0.7% | 4.4% | ||
| Q2 24 | — | 4.1% |
每股收益（稀释后）MRNARUSHA
| Q1 26 | — | $0.77 | ||
| Q4 25 | — | $0.81 | ||
| Q3 25 | $-0.51 | $0.83 | ||
| Q2 25 | — | $0.90 | ||
| Q1 25 | — | $0.73 | ||
| Q4 24 | $-2.91 | $-95.13 | ||
| Q3 24 | $0.03 | $0.97 | ||
| Q2 24 | — | $97.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.1B | — |
| 总债务越低越好 | — | $277.8M |
| 股东权益账面价值 | $9.3B | $2.3B |
| 总资产 | $12.1B | $4.5B |
| 负债/权益比越低杠杆越低 | — | 0.12× |
8季度趋势，按日历期对齐
现金及短期投资MRNARUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | $212.6M | ||
| Q3 25 | $1.1B | $242.0M | ||
| Q2 25 | — | $211.1M | ||
| Q1 25 | — | $228.7M | ||
| Q4 24 | $1.9B | $228.1M | ||
| Q3 24 | $1.6B | $185.1M | ||
| Q2 24 | — | $167.3M |
总债务MRNARUSHA
| Q1 26 | — | $277.8M | ||
| Q4 25 | — | $274.8M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $408.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MRNARUSHA
| Q1 26 | — | $2.3B | ||
| Q4 25 | — | $2.2B | ||
| Q3 25 | $9.3B | $2.2B | ||
| Q2 25 | — | $2.2B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | $10.9B | $2.1B | ||
| Q3 24 | $11.9B | $2.1B | ||
| Q2 24 | — | $2.0B |
总资产MRNARUSHA
| Q1 26 | — | $4.5B | ||
| Q4 25 | — | $4.4B | ||
| Q3 25 | $12.1B | $4.6B | ||
| Q2 25 | — | $4.7B | ||
| Q1 25 | — | $4.7B | ||
| Q4 24 | $14.1B | $4.6B | ||
| Q3 24 | $15.8B | $4.6B | ||
| Q2 24 | — | $4.5B |
负债/权益比MRNARUSHA
| Q1 26 | — | 0.12× | ||
| Q4 25 | — | 0.12× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.19× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-847.0M | — |
| 自由现金流经营现金流 - 资本支出 | $-880.0M | $411.6M |
| 自由现金流率自由现金流/营收 | -86.6% | 24.4% |
| 资本支出强度资本支出/营收 | 3.2% | 2.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.9B | $828.4M |
8季度趋势，按日历期对齐
经营现金流MRNARUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | $112.9M | ||
| Q3 25 | $-847.0M | $367.8M | ||
| Q2 25 | — | $227.6M | ||
| Q1 25 | — | $153.5M | ||
| Q4 24 | $825.0M | $392.3M | ||
| Q3 24 | $-1.6B | $111.7M | ||
| Q2 24 | — | $270.6M |
自由现金流MRNARUSHA
| Q1 26 | — | $411.6M | ||
| Q4 25 | — | $31.9M | ||
| Q3 25 | $-880.0M | $271.2M | ||
| Q2 25 | — | $113.8M | ||
| Q1 25 | — | $45.1M | ||
| Q4 24 | $303.0M | $263.5M | ||
| Q3 24 | $-1.7B | $-20.0M | ||
| Q2 24 | — | $177.2M |
自由现金流率MRNARUSHA
| Q1 26 | — | 24.4% | ||
| Q4 25 | — | 1.9% | ||
| Q3 25 | -86.6% | 15.2% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 2.6% | ||
| Q4 24 | 31.4% | 13.7% | ||
| Q3 24 | -92.2% | -1.1% | ||
| Q2 24 | — | 9.1% |
资本支出强度MRNARUSHA
| Q1 26 | — | 2.0% | ||
| Q4 25 | — | 4.8% | ||
| Q3 25 | 3.2% | 5.4% | ||
| Q2 25 | — | 6.2% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | 54.0% | 6.7% | ||
| Q3 24 | 8.1% | 7.3% | ||
| Q2 24 | — | 4.8% |
现金转化率MRNARUSHA
| Q1 26 | — | — | ||
| Q4 25 | — | 1.75× | ||
| Q3 25 | — | 5.51× | ||
| Q2 25 | — | 3.14× | ||
| Q1 25 | — | 2.55× | ||
| Q4 24 | — | 5.25× | ||
| Q3 24 | -120.46× | 1.41× | ||
| Q2 24 | — | 3.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MRNA
| COVID19 | $971.0M | 96% |
| Other Revenue | $20.0M | 2% |
| Grant | $14.0M | 1% |
| Collaboration Arrangement Including Arrangements With Affiliate | $7.0M | 1% |
| License And Royalty | $2.0M | 0% |
RUSHA
| New and used commercial vehicle sales | $955.1M | 57% |
| Aftermarket products and services sales | $627.2M | 37% |
| Lease and rental sales | $92.3M | 5% |
| Finance and insurance | $5.6M | 0% |
